Hypothalamic orexin/hypocretin (Orx/Hcrt) peptides participate in the regulation of a wide range of physiological processes and are recruited by drugs of abuse. To advance our understanding of the potential of the Orx/Hcrt receptor-1 (Hcrt-r1) as a treatment target for cocaine addiction, the effect of SB334867 [N-(2-methyl-6benzoxazolyl)-N 0 -1,5-n-aphthyridin-4-yl urea], a specific Hcrt-r1 antagonist, on reinstatement elicited by cocaineassociated stimuli versus stimuli associated with a highly palatable conventional reinforcer [sweetened condensed milk (SCM)] was tested. Two separate groups of male Wistar rats were trained to associate a discriminative stimulus (S + ) with the response-contingent availability of cocaine (0.25 mg/0.1 ml/infusion) or SCM [2/1 (v/v)] and subjected to reinstatement tests following extinction of cocaine-reinforced or SCM-reinforced behavior, during which the reinforcers and S + were withheld. Following extinction, presentation of the cocaine or SCM S + produced comparable recovery of responding. Hcrt-r1 blockade by SB334867 (1-10 mg/kg, intraperitoneal) dose-dependently and selectively reversed conditioned reinstatement induced by cocaine-related stimuli, without interfering with reward seeking produced by the same stimulus when conditioned to SCM. The findings suggest an important role for Hcrt-r1 in appetitive behavior controlled by reward-related stimuli with selectivity for cocaine seeking and identify Hcrt-r1 as a potential treatment target for cocaine relapse prevention.
Introduction
Orexin A [Orx-A or hypocretin-1 (Hcrt-1)] and orexin B [Orx-B or hypocretin-2 (Hcrt-2)] are hypothalamic neuropeptides that bind two receptors, Hcrt-r1 and Hcrt-r2 [1] , and regulate many physiological processes, including feeding, energy metabolism, and arousal [2] . Orx/Hcrt neurons in the lateral hypothalamus play a central role in drug-directed behavior [3] . Orx/Hcrt neurons in the lateral hypothalamus are activated by stimuli associated with food, morphine, ethanol, and cocaine [3] . The Hcrt-r1 antagonist SB334867 [N-(2methyl-6-benzoxazolyl)-N 0 -1,5-n-aphthyridin-4-yl urea] blocks cocaine-induced behavioral sensitization and cocaine-induced potentiation of excitatory currents in dopamine neurons of the ventral tegmental area (VTA) [4] . Intra-VTA SB334867 administration reduces the motivation to self-administer cocaine and attenuates the cocaine-induced enhancement of dopamine signaling in the nucleus accumbens [5] . Pharmacological manipulation of the Orx/Hcrt system is particularly effective in modifying the conditioned effects of drug cues in conditioned place preference and reinstatement studies [3, 6] . The present study tested the effect of SB334867 on reinstatement elicited by cocaine-related stimuli versus stimuli conditioned to a potent conventional reinforcer and whether this effect was specific to cocaine seeking.
Methods

Animals
Seventy-five male Wistar rats (Charles River, Wilmington, Massachusetts, USA; 200-250 g upon arrival) were housed, two or three per cage, in a temperaturecontrolled and humidity-controlled vivarium on a reverse 12 h/12 h light/dark cycle with ad-libitum access to food and water. All of the procedures were conducted in strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.
Drugs
Cocaine (National Institute on Drug Abuse, Bethesda, Maryland, USA) was dissolved in sterile physiological saline. Cocaine or saline vehicle was infused intravenously at a volume of 0.1 ml over 4 s. SB334867 (Eli Lilly Research Laboratories, Indianapolis, Indiana, USA) was dissolved in 10% dimethyl sulfoxide (v/v) and 1% hydroxypropyl-b-cyclodextrin (w/v) in sterile water and administered intraperitoneally in a volume of 5 ml/kg, 30 min before behavioral testing.
Apparatus
The animals were trained and tested in standard 29 Â 24 Â 19.5 cm operant conditioning chambers (Med Associates, St. Albans, Vermont, USA) located inside ventilated soundattenuating cubicles. All of the chambers were equipped with two retractable levers (6 cm above the grid floor), a white cue light above each lever, and a house light located at the top of the chamber's front panel. Auditory stimuli consisted of a 70 dB white noise produced by a white noise generator (Med Associates) presented through an 80 O speaker located at the center of the chamber's front panel just below the house light and an intermittent tone (7 kHz, 70 dB) generated by a tone source (Sonalert with volume control; Med Associates) also positioned at the center of the chamber's front panel just above the speaker. Intravenous cocaine infusions were administered using a syringe pump (Razel Scientific Instruments, Stamford, Connecticut, USA) located outside the sound-attenuating cubicles. Sweetened condensed milk (SCM) was delivered using a syringe pump into drinking reservoirs located on the front panel centered between the active and inactive levers, 4 cm above the grid floor. A computer controlled the delivery of fluids, presentation of auditory stimuli, and recording of behavioral data.
Self-administration and conditioning
Behavioral training and testing were performed as previously described [7] [8] [9] . Briefly, rats designated for cocaine reinstatement were surgically prepared with jugular catheters and given 7 days to recover before commencing self-administration training. Rats designated for testing with SCM were not subjected to surgical procedures. Selfadministration of cocaine (0.25 mg/0.1 ml, intravenously, delivered over 4 s) or SCM [2 : 1 (v/v) in distilled water; 0.1 ml delivered into a 0.2 ml receptacle] began on a fixedratio 1 schedule of reinforcement in 120-min (cocaine) or 40-min (SCM) sessions daily, 5 days/week. Responses at the right, active lever were reinforced, followed by a 20-s time-out (TO) period signaled by illumination of a cue light above the active lever. During this time, the lever remained inactive to prevent accidental overdosing with cocaine. To maintain identical training and experimental conditions, the signaled TO period was also in effect during SCM self-administration. Responses at the left, inactive lever had no scheduled consequences.
Following 2 weeks of cocaine or SCM self-administration training, a contingency was introduced whereby responses at the active lever were differentially reinforced in the presence of distinct discriminative stimuli (S D ) that signaled reinforcer availability versus nonavailability. A constant 70 dB white noise served as a discriminative stimulus (S + ) for the availability of the reinforcer (cocaine or SCM), whereas illumination of a 2.8 W house light located at the top of the chamber's front panel served as a discriminative stimulus (S -) that signaled nonavailability of the reinforcer (i.e. saline solution instead of cocaine or no consequence instead of SCM). Sessions were initiated by extension of the levers into the chambers and concurrent onset of the respective S D that remained present until termination of the session by retraction of the levers. In the presence of S + , responses at the right, active lever were reinforced by cocaine or SCM on a fixed-ratio 1 schedule and, similar to training, this was followed by a 20-s TO period signaled by illumination of a cue light above the lever. In the presence of S -, depression of the right active lever was followed by an intermittent tone, during which the lever remained inactive for 20 s. Three daily sessions (each lasting 1 h for the cocaine group and 20 min for the SCM group) separated by 30-min intervals were conducted, with two 'reward' sessions and one 'nonreward' session sequenced in random order. SCM conditioning sessions were restricted to 20 min to avoid satiety by excessive ingestion of SCM and to ensure that the levels of responding during the first and second SCM sessions were comparable [7] [8] [9] . Sessions were initiated by presentation of the respective S D and extension of the levers. The S D remained present until termination of the session by retraction of the levers. After 8 days of training (i.e. a total of 16 'reward' and eight 'nonreward' sessions), both the cocaine and the SCM group were placed under extinction conditions for 1 h daily, during which the reinforcers and S D were withheld until a criterion of five responses per session or less for three consecutive days was reached. Reinstatement tests were then begun under extinction conditions but with reintroduction of the S D , similar to the conditioning phase. To verify that reinstatement was selectively controlled by the reward-paired S D (i.e. S + ), the rats were tested in the presence of the S D paired with nonreward (i.e. S -) on the first day of the reinstatement phase. Two days later, tests of the effects of SB334867 on S + -induced reinstatement were begun. SB334867 was administered 30 min before the onset of the sessions at doses of 0, 1, 3, 10, or 20 mg/kg (intraperitoneally). Each animal was tested only once with one dose of SB334867 according to a between-subjects design [cocaine: 0 mg/kg (n = 11), 1 mg/kg (n = 9), 3 mg/kg (n = 9), and 10 mg/kg (n =10); SCM: 0mg/kg (n = 10), 1 mg/kg (n = 9), 3 mg/kg (n = 9), and 10 mg/kg (n = 9)].
Statistical analysis
Differences in responding at the active lever between the respective reward and nonreward conditions during the last day of the training/conditioning phase were analyzed using paired t-tests, and comparisons between cocaine S + -induced and SCM S + -induced reinstatement (under vehicle conditions) were made using unpaired t-tests. Differences in the number of responses between the extinction and reinstatement phases in the cocaine and SCM groups were analyzed separately using one-way within-subjects analysis of variance (ANOVA). The effects of SB334867 on reinstatement responses induced by cocaine S + or SCM S + were first analyzed using two-way between-subjects ANOVA, followed by separate one-way between-subjects ANOVAs for the cocaine and SCM groups. ANOVAs with significant results were followed by protected least significant difference post-hoc tests or pairwise comparisons.
Results
After conditioning, the rats showed stable cocaine and SCM self-administration and a significant reduction in responding during nonreward sessions (cocaine, t 38 = 15.2, P < 0.001, Fig. 1a ; SCM, t 36 = 44.3, P < 0.001, Fig. 1a ). Responding was then extinguished in sessions during which the reinforcers and stimuli were absent (Fig. 1b) , and the effects of SB334867 on reinstatement elicited by the cocaine or SCM S + were tested. Both stimuli elicited a similar (t 19 = 1.79, P = 0.09, Fig. 1b Fig. 1b ]. In contrast, SB334867 did not prevent the reinstating effect of SCM S + at any dose tested [one-way ANOVA: F (3,33) = 0.09, P > 0.05, Fig. 1b ]. Inactive lever responses remained low (< 4) throughout testing (not shown).
Discussion
The present findings demonstrate that Hcrt-r1 blockade prevents cocaine-seeking behavior without interfering with the motivating effects of a stimulus conditioned to a highly palatable conventional reinforcer. These findings further support a differential role for the Orx/Hcrt system in drugseeking behavior versus normal motivated behavior and are consistent with the hypothesis that the hypothalamic Orx/ Hcrt system is a substrate for cocaine seeking and that Hcrt-r1 plays an important role in the modulation of cocaine-seeking behavior.
Before discussing the implication of the findings, it is necessary to examine the differences in baseline levels of responding during conditioning, which were considerably higher with SCM than with cocaine, although the level of reinstatement induced by the cocaine-associated and SCM-associated stimuli was similar. It is well established, however, that the reinforcing efficacy and rate of responding on fixed-ratio schedules are not necessarily correlated [10, 11] . Indeed, the concentration of SCM used in the present study has been shown to maintain breaking points (an index of reinforcing efficacy) under a progressive-ratio schedule comparable with those measured with cocaine at the present dose [12] [13] [14] . Moreover, the magnitude of the response reinstatement induced by cocaine S + and SCM S + during the reinstatement tests was statistically identical, which was the goal of the present paradigm, suggesting that under the present conditions reliable and comparable conditioning effects were observed for the cocaine and SCM reinforcers, consistent with previous reports [7] [8] [9] 12] .
One hypothesis concerning the control of drug-seeking behavior is that the neural circuits that mediate these effects are common motivational circuits that are more robustly activated by drug-related stimuli and are not specific to addiction-related events. This activation that normally governs responding for natural rewards may have created new motivational states or tilted processes that normally govern responding for natural rewards toward drug-directed behavior [15] . Pharmacological manipulation of the Orx/Hcrt system is particularly effective in modifying the conditioned effects of drug cues in conditioned place preference and reinstatement studies [3, 16, 17] . In the present study, SB334867 exerted a clear preferential effect on cocaine versus SCM seeking. One possible explanation for this specific effect on cocaine seeking is that, during conditioning, cocaine has neuroadaptively altered neural systems that regulate motivation normally directed at natural rewards, which is revealed by pharmacological (e.g. SB334867) manipulations. This hypothesis is consistent with earlier findings that describe maladaptive recruitment of the Orx/ Hcrt system by drugs of abuse, reflected by neuroadaptative changes that occur in the VTA [18] . Self-administration of both cocaine and natural reward induces common, shortlasting, increased glutamatergic function in VTA dopaminergic neurons [18] . This enhanced synaptic strength is persistent and resistant to extinction only in rats that selfadminister cocaine [18] . The participation of the VTA in cocaine-induced neuronal and behavioral changes requires Orx/Hcrt inputs. Hcrt-r1 activation in the VTA is necessary for the development of cocaine-induced locomotor sensitization [4] , and Orx-A/Hcrt-1-mediated N-methyl-D-aspartate receptor plasticity in the VTA is increased in rats that selfadminister cocaine [19] . Short-lasting neuroadaptations in VTA dopaminergic neurons are induced by high-fat chocolate food pellets [19] , suggesting that the Hcrt/Orx-VTA system initially regulates the motivation to obtain reinforcers in general (e.g. drug or highly palatable food). In contrast, druginduced neuroadaptation of the Hcrt/Orx-VTA system is long-lasting, an effect that may be linked to the tilting of this system toward controlling drug-directed behavior.
SB338467 (10-30 mg/kg) decreases discrete cue-induced reinstatement of cocaine seeking [6] . In the present study, SB334867 prevented the conditioned reinstatement of cocaine seeking at a much lower dose (3 mg/kg), with a trend already observed at 1 mg/kg, and was specific to cocaine seeking up to 10 mg/kg. The inhibitory effects of SB334867 on natural reward seeking have been previously described [20] , but it is still unclear as to why SB334867 was seen to suppress both cocaine and natural reward seeking in earlier studies. One hypothesis is that because of the use of higher doses in earlier work (the lowest dose tested in previous studies was the highest dose tested in the present study [6, 20] ), SB334867 might have antagonized Hcrt-r2, which is known to suppress locomotion [6] . Further studies are warranted to clarify the nonspecific effect of SB334867 at higher doses.
Overall, the present data show that antagonizing Hcrt-r1 preferentially reverses the conditioned reinstatement of cocaine versus SCM seeking, suggesting that targeting Hcrt-r1 offers an approach to prevent cocaine seeking without nonspecific side effects that interfere with normal motivated behavior.
